<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: diabetes patients</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Diabetes patients should have more voice in treatment: experts</title>
   	 <description>(HealthDay)—New guidelines meant to provide type 2 diabetes patients with truly individualized care have been issued by the American Diabetes Association and the European Association for the Study of Diabetes.</description>
     <link>http://medicalxpress.com/news/2012-10-diabetes-patients-voice-treatment-experts.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 02 Oct 2012 12:28:59 EST</pubDate>
	 <guid isPermaLink="false">news268399731</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/diabetespati.jpg" width="90" height="90" />
</item>
<item>
     <title>Drugs similar in efficacy for neuropathic pain in diabetes</title>
   	 <description>(HealthDay)—In the treatment of patients with chronic diabetic peripheral neuropathic pain (DPNP), there are no significant differences in pain-relief efficacy between amitriptyline, duloxetine, and pregabalin; however, pregabalin improves sleep continuity and duloxetine improves daytime functioning, according to research published online Sept. 18 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2012-09-drugs-similar-efficacy-neuropathic-pain.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 26 Sep 2012 13:54:00 EST</pubDate>
	 <guid isPermaLink="false">news267886411</guid>
	 
</item>
<item>
     <title>Considerably more patients may benefit from effective antidiabetic drug</title>
   	 <description>The antidiabetic drug metformin is not prescribed for patients with reduced kidney function because the risk of adverse effects has been regarded as unacceptably high. A study at Sahlgrenska Academy, University of Gothenburg, Sweden, has found that the risks have been substantially overrated. As a result, many more patients with diabetes may be able to enjoy the benefits of the medication.</description>
     <link>http://medicalxpress.com/news/2012-09-considerably-patients-benefit-effective-antidiabetic.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 17 Sep 2012 11:23:08 EST</pubDate>
	 <guid isPermaLink="false">news267099779</guid>
	 
</item>
<item>
     <title>Measuring glucose without needle pricks</title>
   	 <description>Pricking a finger everyday is just part of everyday life for many diabetes patients. A non-invasive measurement approach could release them from the constant pain of pin pricks. The linchpin is a biosensor engineered by Fraunhofer researchers: A tiny chip combines measurement and digital analysis – and can be radioed to a mobile device.</description>
     <link>http://medicalxpress.com/news/2012-09-glucose-needle.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 04 Sep 2012 17:30:22 EST</pubDate>
	 <guid isPermaLink="false">news265998600</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/measuringglu.jpg" width="90" height="90" />
</item>
<item>
     <title>Lung cancer risk unaffected by metformin use in diabetes</title>
   	 <description>(HealthDay)—Patients with type 2 diabetes who take metformin do not have a reduced risk of lung cancer, in contrast to previous observational studies, according to a study published online Aug. 24 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2012-08-lung-cancer-unaffected-metformin-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Thu, 30 Aug 2012 16:38:46 EST</pubDate>
	 <guid isPermaLink="false">news265563490</guid>
	 
</item>
<item>
     <title>Low HDL cholesterol ups risk of diabetic nephropathy</title>
   	 <description>(HealthDay) -- High-density lipoprotein cholesterol (HDL-C) is an independent risk factor for the development of diabetic nephropathy, but not retinopathy, in patients with type 2 diabetes, according to research published online Aug. 13 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2012-08-hdl-cholesterol-ups-diabetic-nephropathy.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 22 Aug 2012 19:20:01 EST</pubDate>
	 <guid isPermaLink="false">news264871069</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/lowhdlcholes.jpg" width="90" height="90" />
</item>
<item>
     <title>Long-term type 2 diabetes ups pancreatic cancer mortality</title>
   	 <description>(HealthDay) -- Among patients with pancreatic adenocarcinoma (PAC), those with pre-existing type 2 diabetes mellitus (T2DM) for longer than five years have an increased mortality risk, according to a study published online Aug. 1 in Cancer.</description>
     <link>http://medicalxpress.com/news/2012-08-long-term-diabetes-ups-pancreatic-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 15 Aug 2012 14:27:15 EST</pubDate>
	 <guid isPermaLink="false">news264259581</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/longtermtype.jpg" width="90" height="90" />
</item>
<item>
     <title>Cataract risk up for statin users with type 2 diabetes</title>
   	 <description>(HealthDay) -- Statin use, which is substantially higher in patients with type 2 diabetes, correlates with an increased risk of age-related (AR) cataracts, according to a study published in the August issue of Optometry and Vision Science.</description>
     <link>http://medicalxpress.com/news/2012-08-cataract-statin-users-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 13 Aug 2012 17:00:01 EST</pubDate>
	 <guid isPermaLink="false">news264090667</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cataractrisk.jpg" width="90" height="90" />
</item>
<item>
     <title>Diabetes drugs taken by over 15 million Americans raises risk of bladder cancer</title>
   	 <description>A popular class of diabetes drugs increases patients' risk of bladder cancer, according to a new study published online this month in the Journal of the National Cancer Institute. Researchers from the Perelman School of Medicine at the University of Pennsylvania found that patients taking thiazolidinedione (TZDs) drugs &amp;#150; which account for up to 20 percent of the drugs prescribed to diabetics in the United States -- are two to three times more likely to develop bladder cancer than those who took a sulfonylurea drug, another common class of medications for diabetes.</description>
     <link>http://medicalxpress.com/news/2012-08-diabetes-drugs-million-americans-bladder.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 13 Aug 2012 14:36:47 EST</pubDate>
	 <guid isPermaLink="false">news264087398</guid>
	 
</item>
<item>
     <title>Almost half of type 2 diabetes patients report acute and chronic pain</title>
   	 <description>Almost half of adults with type 2 diabetes report acute and chronic pain, and close to one quarter report neuropathy, fatigue, depression, sleep disturbance and physical or emotional disability, according to a study of more than 13,000 adults conducted by researchers at the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, Calif. The researchers also found significant rates of shortness of breath, nausea and constipation.</description>
     <link>http://medicalxpress.com/news/2012-08-diabetes-patients-acute-chronic-pain.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 08 Aug 2012 10:20:09 EST</pubDate>
	 <guid isPermaLink="false">news263640002</guid>
	 
</item>
<item>
     <title>Linagliptin noninferior to glimepiride in type 2 diabetes</title>
   	 <description>(HealthDay) -- A new drug for type 2 diabetes causes significantly less weight gain and may carry lower risks for hypoglycemia (low blood sugar), heart attack and stroke than standard medications, a new study indicates.</description>
     <link>http://medicalxpress.com/news/2012-06-linagliptin-noninferior-glimepiride-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Thu, 28 Jun 2012 18:05:05 EST</pubDate>
	 <guid isPermaLink="false">news260125485</guid>
	 
</item>
<item>
     <title>Physical fitness may improve survival among diabetes patients with heart dysfunction</title>
   	 <description>Being physically fit may improve survival rates among diabetes patients with a particular type of heart abnormality, a new study determines. The results will be presented at The Endocrine Society's 94th Annual Meeting in Houston.</description>
     <link>http://medicalxpress.com/news/2012-06-physical-survival-diabetes-patients-heart.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 25 Jun 2012 10:14:42 EST</pubDate>
	 <guid isPermaLink="false">news259838044</guid>
	 
</item>
<item>
     <title>Common diabetes drugs associated with increased risk of death</title>
   	 <description>Compared to another popular drug, three widely used diabetes medications are associated with a greater risk of death, a large new analysis finds. The results will be presented at The Endocrine Society's 94th Annual Meeting in Houston.</description>
     <link>http://medicalxpress.com/news/2012-06-common-diabetes-drugs-death.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 25 Jun 2012 09:50:01 EST</pubDate>
	 <guid isPermaLink="false">news259835547</guid>
	 
</item>
<item>
     <title>Experimental diabetes drugs offer patients hope</title>
   	 <description>Some experimental diabetes treatments in late testing offer patients hope of better controlling their blood sugar and weight and preventing dangerously low blood sugar, all big challenges for millions of diabetics.</description>
     <link>http://medicalxpress.com/news/2012-06-experimental-diabetes-drugs-patients.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 11 Jun 2012 03:56:07 EST</pubDate>
	 <guid isPermaLink="false">news258605418</guid>
	 
</item>
<item>
     <title>Metabolic syndrome linked to arterial stiffness in CKD</title>
   	 <description>(HealthDay) -- For patients with chronic kidney disease (CKD), those with metabolic syndrome (MetS) have increased arterial stiffness but no increase in endothelial dysfunction, compared to those without MetS, according to a study published online May 29 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2012-06-metabolic-syndrome-linked-arterial-stiffness.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 04 Jun 2012 17:38:17 EST</pubDate>
	 <guid isPermaLink="false">news258050289</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/metabolicsyn.jpg" width="90" height="90" />
</item>
<item>
     <title>'Jack Spratt' diabetes gene identified</title>
   	 <description>Type 2 diabetes is popularly associated with obesity and a sedentary lifestyle. However, just as there are obese people without type 2 diabetes, there are lean people with the disease.</description>
     <link>http://medicalxpress.com/news/2012-06-jack-spratt-diabetes-gene.html</link>
	 <category>Genetics</category>
	 <pubDate>Fri, 01 Jun 2012 09:40:02 EST</pubDate>
	 <guid isPermaLink="false">news257762388</guid>
	 
</item>
<item>
     <title>Preventing diabetes: Researchers measure loss of human pancreas cells</title>
   	 <description>(Medical Xpress) -- A Yale University-led research team has developed a way to measure the loss of insulin-producing islet cells in the human pancreas. The death of those beta cells leads to diabetes. The finding is a crucial step in developing therapies to preserve insulin production and slow or halt the progress of diabetes. The study appears in the June issue of the Journal of Nuclear Medicine.</description>
     <link>http://medicalxpress.com/news/2012-06-diabetes-loss-human-pancreas-cells.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 01 Jun 2012 06:44:59 EST</pubDate>
	 <guid isPermaLink="false">news257751721</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/preventingdi.jpg" width="90" height="90" />
</item>
<item>
     <title>Aggressively controlling glucose levels may not reduce kidney failure in Type 2 diabetes</title>
   	 <description>A review of data from seven clinical trials suggests that intensive glucose control is associated with reduced risk of microalbuminuria and macroalbuminuria (conditions characterized by excessive levels of protein in the urine usually resulting from damage to the filtering units of the kidneys), according to a report published in the May 28 issue of Archives of Internal Medicine, a JAMA Network publication.</description>
     <link>http://medicalxpress.com/news/2012-05-aggressively-glucose-kidney-failure-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 28 May 2012 16:00:29 EST</pubDate>
	 <guid isPermaLink="false">news257416064</guid>
	 
</item>
<item>
     <title>U.S. sees drop in deaths linked to diabetes</title>
   	 <description>(HealthDay) -- Healthier lifestyles and better disease management led to a sharp drop in death rates for Americans with diabetes between 1997 and 2006,  especially deaths caused by heart disease and stroke, a new federal government report shows.</description>
     <link>http://medicalxpress.com/news/2012-05-deaths-linked-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 22 May 2012 18:40:02 EST</pubDate>
	 <guid isPermaLink="false">news256929395</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/usseesdropin.jpg" width="90" height="90" />
</item>
<item>
     <title>Various metabolic risk factors could be linked to diabetes-related pain with major implications for treatment</title>
   	 <description>Around 1 in 50 people in the general population and 1 in 6 of those aged over 40 years experience neuropathy (damage to the nerves of the peripheral nervous system), which can cause numbness, tingling, pain, or weakness. The most common cause of neuropathy is diabetes, and up to half of diabetes patients can be affected. Currently, among the only treatments for neuropathy are glucose control (which often only delays it) and pain management. Yet less than half of patients are treated for pain, despite the availability of many effective therapies . Growing evidence suggests that various metabolic risk factors, including prediabetes, could be linked with neuropathy and thus be targets for new disease-modifying drugs. The issues are discussed in a Review in the June issue of The Lancet Neurology, by Dr Brian C Callaghan and colleagues, all of the University of Michigan, Ann Arbor, MI, USA.</description>
     <link>http://medicalxpress.com/news/2012-05-metabolic-factors-linked-diabetes-related-pain.html</link>
	 <category>Neuroscience</category>
	 <pubDate>Thu, 17 May 2012 18:30:03 EST</pubDate>
	 <guid isPermaLink="false">news256493392</guid>
	 
</item>
<item>
     <title>Doubts over long term impact of group education for diabetes patients</title>
   	 <description>The benefits of a one-off group education programme for people with newly diagnosed type 2 diabetes are not sustained over the long term, concludes a study published on BMJ today.</description>
     <link>http://medicalxpress.com/news/2012-04-term-impact-group-diabetes-patients.html</link>
	 <category>Diabetes</category>
	 <pubDate>Thu, 26 Apr 2012 18:30:02 EST</pubDate>
	 <guid isPermaLink="false">news254672945</guid>
	 
</item>
<item>
     <title>CV autonomic neuropathy risk for CVD despite albumin status</title>
   	 <description>(HealthDay) -- Cardiovascular autonomic neuropathy (CAN) appears to affect the risk of cardiovascular disease even in type 1 diabetes patients with normal albumin excretion rates, according to a study published online April 12 in Diabetes.</description>
     <link>http://medicalxpress.com/news/2012-04-cv-autonomic-neuropathy-cvd-albumin.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 19 Apr 2012 04:30:01 EST</pubDate>
	 <guid isPermaLink="false">news254024521</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/cvautonomicn.jpg" width="90" height="90" />
</item>
<item>
     <title>Naturopathic care can improve blood sugar, mood in diabetes</title>
   	 <description>A new joint study by Group Health Research Institute and Bastyr University Research Institute found that type 2 diabetes patients who received naturopathic care (as an adjunct to conventional care) had lower blood-sugar levels, better eating and exercise habits, improved moods, and a stronger sense of control over their condition than did patients receiving only conventional care.</description>
     <link>http://medicalxpress.com/news/2012-04-naturopathic-blood-sugar-mood-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Wed, 18 Apr 2012 13:14:52 EST</pubDate>
	 <guid isPermaLink="false">news253973681</guid>
	 
</item>
<item>
     <title>One cause of fatty deposits in the hearts of diabetes patients settled</title>
   	 <description>The impaired substrate metabolism of diabetes patients is often expressed in an increase in fatty deposits in the cells of the heart muscle. Until now, the exact cause of this was unknown. Now, Austrian researchers at the MedUni Vienna in the Division of Endocrinology and Metabolism of MedUni Vienna in cooperation with the MR Centre of Excellence Vienna have shown that high blood sugar in combination with high levels of insulin &amp;#150; not an influx of fats &amp;#150; results in such deposits within a few hours. This could form the basis for even more heart-friendly treatments of diabetes patients, especially in the early stages of the disease.</description>
     <link>http://medicalxpress.com/news/2012-04-fatty-deposits-hearts-diabetes-patients.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 16 Apr 2012 09:06:23 EST</pubDate>
	 <guid isPermaLink="false">news253785971</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/onecauseoffa.jpg" width="90" height="90" />
</item>
<item>
     <title>Isomaltulose doesn't improve glycemic control in diabetes</title>
   	 <description>(HealthDay) -- For patients with type 2 diabetes, substitution of sucrose with isomaltulose is not associated with improved glycemic control (measured by hemoglobin A1c [HbA1c] levels) at 12 weeks, according to a study published online April 9 in Diabetes Care.</description>
     <link>http://medicalxpress.com/news/2012-04-isomaltulose-doesnt-glycemic-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 13 Apr 2012 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news253540617</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/isomaltulose.jpg" width="90" height="90" />
</item>
<item>
     <title>Aspirin enhances platelet isoprostanes in type 2 diabetes</title>
   	 <description>(HealthDay) -- For patients with type 2 diabetes mellitus (T2DM) who are treated with aspirin, isoprostanes are overproduced, which is linked with enhanced platelet recruitment, according to a study published online March 16 in Diabetes.</description>
     <link>http://medicalxpress.com/news/2012-03-aspirin-platelet-isoprostanes-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 23 Mar 2012 14:40:39 EST</pubDate>
	 <guid isPermaLink="false">news251732392</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/aspirinenhan.jpg" width="90" height="90" />
</item>
<item>
     <title>Mentoring provides health benefits for African American veterans with diabetes</title>
   	 <description>Intervention by peer mentors has a statistically significant effect on improving glucose control in African American veterans with diabetes, according to a study by researchers at the Perelman School of Medicine at the University of Pennsylvania and the Philadelphia VA Center for Health Equity Research and Promotion (CHERP). Full results of the study were published in the March 20th issue of the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2012-03-health-benefits-african-american-veterans.html</link>
	 <category>Diabetes</category>
	 <pubDate>Mon, 19 Mar 2012 17:24:40 EST</pubDate>
	 <guid isPermaLink="false">news251396672</guid>
	 
</item>
<item>
     <title>Gene profile correlates with glycemia in type 1 diabetes</title>
   	 <description>(HealthDay) -- A gene expression profile in peripheral blood correlates with glycemic control in the first year for patients recently diagnosed with type 1 diabetes, according to a study published online March 8 in Diabetes.</description>
     <link>http://medicalxpress.com/news/2012-03-gene-profile-glycemia-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 16 Mar 2012 14:27:16 EST</pubDate>
	 <guid isPermaLink="false">news251126828</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/geneprofilec.jpg" width="90" height="90" />
</item>
<item>
     <title>Increasing shift from islet antibody positivity to diabetes</title>
   	 <description>(HealthDay) -- There is an increase in both the prevalence and levels of islet antigen-2 and zinc transporter 8, as well as in autoantibodies, in newly diagnosed type 1 diabetes patients during a period of rising disease incidence, according to a study published in the March issue of Diabetes.</description>
     <link>http://medicalxpress.com/news/2012-03-shift-islet-antibody-positivity-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Fri, 02 Mar 2012 14:20:01 EST</pubDate>
	 <guid isPermaLink="false">news249914555</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/increasingsh.jpg" width="90" height="90" />
</item>
<item>
     <title>Researchers pave the way for improving treatment for Type 2 diabetes</title>
   	 <description>In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body. This discovery has important implications for drugs currently in development to treat Type 2 diabetes, a disease which is diagnosed every 10 seconds somewhere throughout the world.</description>
     <link>http://medicalxpress.com/news/2012-02-pave-treatment-diabetes.html</link>
	 <category>Diabetes</category>
	 <pubDate>Tue, 07 Feb 2012 10:12:52 EST</pubDate>
	 <guid isPermaLink="false">news247831963</guid>
	 
</item>


</channel>
</rss>
